USP22 and infection: The data showed that at 8 and 24 h post-infection (Fig. 3), specific silencing of USP22 and CDC27 inhibited bacterial replication throughout the intracellular infection period, compared to the negative control RNAi-treated or untreated cells (Fig. 3A).